What Is Tigecycline-Induced Dysbiosis?
Tigecycline, a glycylcycline antibiotic, disrupts gut microbiota by broadly killing bacteria, including beneficial anaerobes. This leads to dysbiosis—imbalanced microbial communities with reduced diversity, overgrowth of resistant pathogens, and loss of short-chain fatty acid producers.[1]
Common Immediate Consequences
Dysbiosis from tigecycline raises infection risk due to gut barrier breakdown:
- Clostridioides difficile (C. diff) infection: Tigecycline spares C. diff spores, enabling overgrowth. Rates reach 10-20% in exposed patients, causing severe diarrhea and colitis.[2]
- Secondary bacteremia: Pathogens like Klebsiella or Enterococcus translocate from gut to bloodstream, especially in ICU patients.[3]
Why Does Tigecycline Cause More Dysbiosis Than Other Antibiotics?
Its static activity and biliary excretion maintain high gut levels, wiping out Bacteroidetes and Firmicutes while selecting multidrug-resistant strains. Recovery takes 2-4 weeks post-treatment, longer than with beta-lactams.[4]
Long-Term Health Risks
Persistent dysbiosis links to:
- Metabolic changes: Reduced butyrate production impairs gut integrity, raising obesity and diabetes risk.
- Immune dysregulation: Altered T-cell responses increase susceptibility to infections for months.
- Systemic inflammation: Elevated cytokines contribute to conditions like irritable bowel syndrome or hepatic injury in vulnerable patients.[5]
How Long Until Gut Microbiome Recovers?
Diversity partially rebounds in 1-2 weeks, but full restoration can take 6 months. Probiotics (e.g., Saccharomyces boulardii) or fecal microbiota transplant speed recovery and cut C. diff recurrence by 50-70%.[6]
Prevention and Management Strategies